LKFTLakefront Biotherapeutics NV

$29.74-13% 1Y

Price

-13%1Y

End-of-day closes, not the intraday tick.

More going right than wrong

Quality mixed, nothing alarming, growing in the filings, the market undecided.

RyuScore 12 of 100: see how it is built
P/En/a
Market value$1.90B
1 year-13%
5 years-48%

Charts

As reported to the SEC, without any scoring.

For the full year FY2025, revenue was €1.11B (+304% year on year) and net income €321M.

Why these answers

Each answer with the checks it was read from. Open one for the numbers.

5/19 checks · as of Oct 9, 2026

Conflicts between checks are named, never averaged, and thin data says so.